Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Ortho Regenerative Technologies Inc. (C:ORTH)

Business Focus: Biotechnology & Medical Research

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for ORTH within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Jun 30, 2020 07:00 ET
Ortho Regenerative Technologies Reports its First Quarter 2021 Results
Preclinical results confirm safety of Ortho-R and statistical significance over standard of care for rotator cuff repair. Ortho-R development program entering US clinical trial regulatory process with FDA. Entered into strategic agreement with Ingenew Pharmaceuticals to expand Ortho Regenerative Technologies' proprietary biopolymer platform to include the delivery of therapeutics. Closed $1.1 Million Private Placement, including $400,000 from management and Board members. MONTREAL, June 30, 2020 /CNW Telbec/ - Ortho Regenerative Technologies Inc. (CSE: ORTH) ("Ortho RTI" or the "Company"),
Read full article
Jun 22, 2020 07:00 ET
Ortho Regenerative Technologies Announces the Nomination of a New Independent Chairman of the Board
MONTREAL, June 22, 2020 /CNW Telbec/ - Ortho Regenerative Technologies Inc. (CSE: ORTH) ("Ortho RTI" or the "Company"), an emerging orthobiologics company, today announced the appointment of Mr. Michael Atkin as its new independent Chairman of the Board. Mr. Atkin is succeeding Mr. Steve Saviuk. Mr. Saviuk will continue to serve the Company as a Board member. The change is effective immediately.
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
N/A
--
--
Price to Sales - TTM
--
10.29
8.87
Price to Book - most recent quarter
--
4.59
2.60
Price to Cash Flow per share - TTM
--
20.92
11.97
Price to Free Cash Flow per share - TTM
--
54.68
22.01
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Jun 15, 2020100
Feb 15, 2020500
Dec 31, 196900
See Short Report

Business Summary

Sector:  Healthcare Industry:  Biotechnology & Medical Research

Ortho Regenerative Technologies Inc is a Canada-based biotechnology company. The Company is developing a platform for the repair of tears to soft tissues in joints, and for articular cartilage repair, to restore healthy joint motion and prevent or delay osteoarthritis. The Company's initial focus is in creating new treatments for tears to the meniscus in the knee and the shoulder cuff. The Company's biopolymer has been designed for the healing rates of sports related injuries to ligaments, tendons and cartilage. The polymer can be directly placed into the site of injury by a surgeon during a routine operative procedure without significantly extending the time of the surgery and without further intervention.

See business summary

 

Twitter

Search (past week) for $ORTH.CA

  • No tweets found